TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 15.4M
Total Liabilities 9.2M
Shareholders Equity 6.2M
Debt to Equity 1.48

Cash Flow Metrics

Revenue & Profitability Trend

Yy Group Holding Income Statement From 2021 to 2024

Metric2024202320222021
Revenue i41.1M31.8M20.0M17.5M
Cost of Goods Sold i35.8M28.1M17.5M15.2M
Gross Profit i5.3M3.7M2.6M2.3M
Gross Margin % i12.8%11.5%12.8%13.2%
Operating Expenses
Research & Development i----
Selling, General & Administrative i11.1M4.0M3.2M2.8M
Other Operating Expenses i-1.7M-1.8M-2.0M-985.7K
Total Operating Expenses i9.4M2.2M1.3M1.8M
Operating Income i-4.1M1.4M1.3M517.8K
Operating Margin % i-10.1%4.5%6.4%3.0%
Non-Operating Items
Interest Income i----
Interest Expense i118.7K109.9K117.1K65.0K
Other Non-Operating Income3.8K-27.8K-57.1K-10.4K
Pre-tax Income i-4.6M1.1M903.5K348.2K
Income Tax i275.9K224.3K142.2K-14.7K
Effective Tax Rate % i0.0%20.6%15.7%-4.2%
Net Income i-4.8M864.0K761.3K362.9K
Net Margin % i-11.8%2.7%3.8%2.1%
Key Metrics
EBITDA i-4.1M1.5M1.4M812.0K
EPS (Basic) i-$0.02$0.02$0.01
EPS (Diluted) i-$0.02$0.02$0.01
Basic Shares Outstanding i-378770993067425028792943
Diluted Shares Outstanding i-378770993067425028792943

Income Statement Trend

Yy Group Holding Balance Sheet From 2021 to 2024

Metric2024202320222021
Assets
Current Assets
Cash & Equivalents i836.9K467.2K161.0K66.0K
Short-term Investments i--074.0K
Accounts Receivable i8.2M7.0M4.2M4.1M
Inventory i----
Other Current Assets-257.3K31.6K23.9K
Total Current Assets i13.4M10.2M5.2M4.5M
Non-Current Assets
Property, Plant & Equipment i129.7K78.5K77.0K0
Goodwill i----
Intangible Assets i----
Long-term Investments----
Other Non-Current Assets35.7K73878.5K105.7K
Total Non-Current Assets i2.0M466.4K568.1K656.4K
Total Assets i15.4M10.7M5.8M5.1M
Liabilities
Current Liabilities
Accounts Payable i1.3M891.8K520.0K474.6K
Short-term Debt i3.9M2.9M1.4M1.8M
Current Portion of Long-term Debt----
Other Current Liabilities----
Total Current Liabilities i8.0M6.0M3.5M4.2M
Non-Current Liabilities
Long-term Debt i1.1M538.8K1.3M924.0K
Deferred Tax Liabilities i38.4K0--
Other Non-Current Liabilities----
Total Non-Current Liabilities i1.2M538.8K1.3M924.0K
Total Liabilities i9.2M6.5M4.8M5.1M
Equity
Common Stock i5.3M3.6M1.2M1.0M
Retained Earnings i-4.3M545.8K-306.5K-1.0M
Treasury Stock i----
Other Equity----
Total Shareholders Equity i6.2M4.1M941.6K-27.8K
Key Metrics
Total Debt i5.0M3.5M2.7M2.7M
Working Capital i5.5M4.2M1.7M239.8K

Balance Sheet Composition

Yy Group Holding Cash Flow Statement From 2021 to 2024

Metric2024202320222021
Operating Activities
Net Income i-4.8M864.0K761.3K362.9K
Depreciation & Amortization i371.5K288.6K340.6K398.8K
Stock-Based Compensation i5.2M00-
Working Capital Changes i-431.8K-756.9K-282.4K-350.6K
Operating Cash Flow i961.5K947.8K1.3M566.0K
Investing Activities
Capital Expenditures i-101.2K-224.2K-112.1K-241.2K
Acquisitions i----
Investment Purchases i----
Investment Sales i----
Investing Cash Flow i-101.2K-224.2K-112.1K-241.2K
Financing Activities
Share Repurchases i-1.0M00-
Dividends Paid i----
Debt Issuance i1.3M2.8M2.3M862.0K
Debt Repayment i-1.2M-1.9M-3.3M-1.0M
Financing Cash Flow i2.1M470.4K-726.3K-180.1K
Free Cash Flow i-1.6M-172.5K823.2K182.9K
Net Change in Cash i2.9M1.2M452.5K144.7K

Cash Flow Trend

Yy Group Holding Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 20.23
Price to Book 11.12
Price to Sales 1.85

Profitability Ratios

Profit Margin -11.77%
Operating Margin -26.81%
Return on Equity -93.74%
Return on Assets -24.14%

Financial Health

Current Ratio 1.68
Debt to Equity 81.32

Per Share Data

EPS (TTM) $-0.14
Book Value per Share $0.17
Revenue per Share $1.22

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
yygh75.9M20.2311.12-93.74%-11.77%81.32
Rollins 28.1B57.3719.4536.52%13.71%66.99
Service 11.3B21.946.8932.72%12.58%292.19
Medifast 155.5M42.880.671.73%0.76%6.05
Regis 47.7M0.520.69548.07%49.34%535.95
Medirom Healthcare 14.2M9.470.0222.96%1.79%400.54

Financial data is updated regularly. All figures are in the company's reporting currency.